You are here

ADAP Hepatitis C (HCV) Decision Tree

July 2018

NASTAD

Decision tree for providers to illustrate and clarify the myriad treatment coverage options available to people living with HIV and HCV, including ADAP.

Utilization data suggests that the broader HCV health care landscape remains confusing for clients and providers to navigate. Many providers do not maximize all available HCV treatment opportunities, instead relying solely on pharmaceutical companies’ patient assistance and cost-sharing assistance programs. 

Total views: 43
lifted